<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chapman RM</submitter><funding>Eli Lilly</funding><funding>NIA NIH HHS</funding><funding>Taisho Toyama Pharmaceutical Company</funding><funding>Eisai</funding><funding>National Institutes of Health</funding><funding>Department of Defense</funding><funding>Merck</funding><funding>National Institute on Aging</funding><funding>Genentech/Roche</funding><funding>NEI NIH HHS</funding><funding>National Eye Institute</funding><funding>Biogen</funding><funding>U.S. Department of Defense</funding><funding>National Institute of Mental Health</funding><funding>AstraZeneca</funding><funding>Avanir</funding><funding>Toyama</funding><funding>Janssen Alzheimer Initiative</funding><pagination>604-614</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6215980</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Developing biomarkers that distinguish individuals with Alzheimer's disease (AD) from those with normal cognition remains a crucial goal for improving the health of older adults. We investigated adding brain spatial information to temporal event-related potentials (ERPs) to increase AD identification accuracy over temporal ERPs alone.&lt;h4>Methods&lt;/h4>With two-step principal components analysis, we applied multivariate analyses that incorporated temporal and spatial ERP information from a cognitive task. Discriminant analysis used temporospatial ERP scores to classify participants as belonging to either the AD or healthy control group.&lt;h4>Results&lt;/h4>Temporospatial ERPs produced a cross-validated area under the curve of 0.84. Adding spatial information through a formal p</pubmed_abstract><journal>Alzheimer's &amp; dementia (Amsterdam, Netherlands)</journal><pubmed_title>Temporospatial components of brain ERPs as biomarkers for Alzheimer's disease.</pubmed_title><pmcid>PMC6215980</pmcid><funding_grant_id>R01 AG041313</funding_grant_id><funding_grant_id>P30 EY001319</funding_grant_id><funding_grant_id>R01 AG018880</funding_grant_id><pubmed_authors>Kamalyan L</pubmed_authors><pubmed_authors>Mapstone M</pubmed_authors><pubmed_authors>Gardner MN</pubmed_authors><pubmed_authors>Antonsdottir IM</pubmed_authors><pubmed_authors>Klorman R</pubmed_authors><pubmed_authors>Porsteinsson AP</pubmed_authors><pubmed_authors>Chapman RM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Temporospatial components of brain ERPs as biomarkers for Alzheimer's disease.</name><description>&lt;h4>Introduction&lt;/h4>Developing biomarkers that distinguish individuals with Alzheimer's disease (AD) from those with normal cognition remains a crucial goal for improving the health of older adults. We investigated adding brain spatial information to temporal event-related potentials (ERPs) to increase AD identification accuracy over temporal ERPs alone.&lt;h4>Methods&lt;/h4>With two-step principal components analysis, we applied multivariate analyses that incorporated temporal and spatial ERP information from a cognitive task. Discriminant analysis used temporospatial ERP scores to classify participants as belonging to either the AD or healthy control group.&lt;h4>Results&lt;/h4>Temporospatial ERPs produced a cross-validated area under the curve of 0.84. Adding spatial information through a formal p</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018</publication><modification>2025-05-29T20:47:26.016Z</modification><creation>2025-05-29T20:47:26.016Z</creation></dates><accession>S-EPMC6215980</accession><cross_references><pubmed>30417070</pubmed><doi>10.1016/j.dadm.2018.08.002</doi></cross_references></HashMap>